Daniel M. Scolnick is a registered patent attorney with Pepper Hamilton LLP, resident in the Berwyn office. Dr. Scolnick concentrates his practice in intellectual property, primarily on intellectual property transactions and counseling, with a substantial portion of his work directed to patent preparation and prosecution, due diligence and licensing matters. Dr. Scolnick also provides litigation support to our patent litigators.
Dr. Scolnick’s clients include venture capital groups, academic institutions, start-up biotechnology companies, Fortune 500 companies, mid-size biotechnology and pharmaceutical companies, and nutritional supplement companies. Dr. Scolnick’s experience, along with his exposure to other areas of technology, allow him to appreciate issues critical to the firm’s biotechnology and life science clients.
As a Ph.D. candidate and a post-doctoral fellow at the University of Pennsylvania, Dr. Scolnick acquired extensive experience in the biochemistry, protein chemistry and genetics while cloning and characterizing a novel cell cycle checkpoint gene and characterizing the genetics of neurodegenerative disease in fruit flies. In particular, he regularly investigated and characterized genes and proteins using standard molecular biology and protein chemistry techniques. While at the University of Pennsylvania, Dr. Scolnick also worked in the area of biochemistry related to the isolation, purification and structural characterization of cellular proteins. As an undergraduate he focused on defining the structure and function of anticonvulsants including modeling the drugs to define the areas essential to their activity. Dr. Scolnick’s experience also includes synthesis and analytical work at the University of Pennsylvania’s chemistry department as a summer fellow where he assisted in analyzing synthesis and purification techniques involving nanomaterials, such as “Bucky Balls.” Dr. Scolnick has also authored eight peer-reviewed scientific articles including one that was published in the journal Nature that described the cloning and characterization of a novel cell cycle gene that has been subsequently found to be intricately involved in the progression of many cancers.